- Home
- CHPT vs DNA Comparison
CHPT vs DNA Comparison
Compare CHPT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHPT
- DNA
- Stock Information
- Founded
- CHPT 2007
- DNA 2008
- Country
- CHPT United States
- DNA United States
- Employees
- CHPT N/A
- DNA N/A
- Industry
- CHPT Industrial Specialties
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHPT Consumer Discretionary
- DNA Health Care
- Exchange
- CHPT Nasdaq
- DNA Nasdaq
- Market Cap
- CHPT 321.7M
- DNA 466.4M
- IPO Year
- CHPT N/A
- DNA N/A
- Fundamental
- Price
- CHPT $0.70
- DNA $6.94
- Analyst Decision
- CHPT Hold
- DNA Sell
- Analyst Count
- CHPT 10
- DNA 3
- Target Price
- CHPT $1.58
- DNA $9.67
- AVG Volume (30 Days)
- CHPT 10.5M
- DNA 1.1M
- Earning Date
- CHPT 06-04-2025
- DNA 05-06-2025
- Dividend Yield
- CHPT N/A
- DNA N/A
- EPS Growth
- CHPT N/A
- DNA N/A
- EPS
- CHPT N/A
- DNA N/A
- Revenue
- CHPT $417,083,000.00
- DNA $237,417,000.00
- Revenue This Year
- CHPT $12.03
- DNA N/A
- Revenue Next Year
- CHPT $26.85
- DNA $15.26
- P/E Ratio
- CHPT N/A
- DNA N/A
- Revenue Growth
- CHPT N/A
- DNA 13.76
- 52 Week Low
- CHPT $0.51
- DNA $5.00
- 52 Week High
- CHPT $2.44
- DNA $23.29
- Technical
- Relative Strength Index (RSI)
- CHPT 52.86
- DNA 44.32
- Support Level
- CHPT $0.69
- DNA $6.65
- Resistance Level
- CHPT $0.79
- DNA $7.62
- Average True Range (ATR)
- CHPT 0.05
- DNA 0.51
- MACD
- CHPT 0.00
- DNA -0.08
- Stochastic Oscillator
- CHPT 37.40
- DNA 16.34
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.